Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
BioTech
Pharmaceuticals
Medical Devices
About Investor
Anders Hove is Founder and Partner at Acorn Bioventures, a New York–based biotech investor deploying $100 K–$5 M across seed, crossover, and public-market financings. His most recent position is a reported stake in Candel Therapeutics, and he operates out of New York, New York. Dr. Hove earned an MD from the University of Copenhagen and an MBA from INSEAD, and he formerly served as a Managing General Partner at Venrock and portfolio manager at BB Biotech.
Previous investments
Intuity Medical
12M |2011
64M |2010
Edge Therapeutics
56M |2015
Mevion Medical Systems
7M |2007
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP